The overall purpose of the SC Cardiovascular COBRE Gene Function Core Is to provide intellectual and physical resources (specifically transgenic and gene targeted mice) to enhance our understanding of cardiovascular malformations and adult cardiac disease, while supporting all investigators around the state of SC in using genetically modified mice. The renewal proposal of this Core builds upon the previous investments of the NIH/NCRR COBRE Phase I and II programs, NIH/NCRR Shared Instrumentation Grant, NIH/NCRR construction grant, and institutional support. The Gene Function COBRE Core integrates two existing state-of-the-art intramural shared resource facilities each of which are unique within the state of SC: the MUSC Transgenic Facility and the MUSC Gene Targeting Facility. The Gene Function Core also offers plasmid construction, optimizing PCR, genotyping, mentoring PIs, and training lab personnel. Since 2001 the COBRE Gene Function Core has serviced over 50 different investigators and facilitated their research involving >$45 million of extramural grant support. During this time period the Gene Function Core has added new services, like cryopreservation, rederivation, and in vitro fertilization, to facilitate the use and transfer of genetically modified mice. A critical addition has been the ability to make both transgenic and gene targeted mice in the C57BL/6 strain. Since the Gene Function Core provides the only means to make genetically modified mice within the State of South Carolina, this Core will continue to support the research programs of MUSC faculty and throughout the state, as we have over the past 10 years. The major aims of the Gene Function Core during Phase III COBRE funding are: 1) to expand the use of genetically modified mice through consultation and education, 2) to provide the expertise and resources required to design and generate DNA constructs for production of genetically modified mice, 3) to generate new transgenic mice, 4) to generate new gene-targeted mice, 5) to employ business practices and pricing that foster long term sustainability of the core, and 6) to facilitate the mission of the Cardiovascular Developmental Biology Center (CDBC) in understanding the developmental basis of cardiovascular diseases.

Public Health Relevance

The Gene Function Core of the SC Cardiovascular COBRE is the only place in the state of Sout Carolina that provides genetically modified and associated services, along with education and outreach, to facilitate biomedical research throughout the state and region.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
1P30GM103342-01
Application #
8471620
Study Section
Special Emphasis Panel (ZRR1-RI-B (01))
Project Start
Project End
Budget Start
2012-08-01
Budget End
2013-04-30
Support Year
1
Fiscal Year
2012
Total Cost
$294,999
Indirect Cost
$95,000
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Panganiban, Clarisse H; Barth, Jeremy L; Darbelli, Lama et al. (2018) Noise-induced dysregulation of Quaking RNA binding proteins contributes to auditory nerve demyelination and hearing loss. J Neurosci :
Yu, Jin; Zhu, Hong; Taheri, Saeid et al. (2018) Impact of nutrition on inflammation, tauopathy, and behavioral outcomes from chronic traumatic encephalopathy. J Neuroinflammation 15:277
Alawieh, Ali; Langley, E Farris; Weber, Shannon et al. (2018) Identifying the role of complement in triggering neuroinflammation after traumatic brain injury. J Neurosci :
Sun, Bowen; Wang, Geng; Liu, Huidong et al. (2018) Oridonin inhibits aberrant AKT activation in breast cancer. Oncotarget 9:23878-23889
Noble, Kenyaria V; Reyzer, Michelle L; Barth, Jeremy L et al. (2018) Use of Proteomic Imaging Coupled With Transcriptomic Analysis to Identify Biomolecules Responsive to Cochlear Injury. Front Mol Neurosci 11:243
Daoud, Abdelkader; Gopal, Udhayakumar; Kaur, Jasmine et al. (2017) Molecular and functional crosstalk between extracellular Hsp90 and ephrin A1 signaling. Oncotarget 8:106807-106819
Pulkoski-Gross, Michael J; Uys, Joachim D; Orr-Gandy, K Alexa et al. (2017) Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis. Prostaglandins Other Lipid Mediat 130:47-56
Chen, Wei; Zhang, Yong-Mei; Davies, Christopher (2017) Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa. Antimicrob Agents Chemother 61:
Richards, Dylan; Jia, Jia; Yost, Michael et al. (2017) 3D Bioprinting for Vascularized Tissue Fabrication. Ann Biomed Eng 45:132-147
Beiko, Tatsiana; Janech, Michael G; Alekseyenko, Alexander V et al. (2017) Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis 4:204-216

Showing the most recent 10 out of 71 publications